Kyowa Kirin International (KKI) represents the International region of the Kyowa Kirin Group, a Japan-based Global Specialty Pharmaceutical Company that discovers, develops and delivers novel medicines with life-changing value. KKI employs nearly 800 people across Europe and the Middle East. We are a highly successful and rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of innovative
Making people smile
Our values guide us every step of the way. At Kyowa Kirin, our ambition is clear: to help bring a smile to everyone we work with and serve, whether it’s through a medicine to treat a rare disease, a collaboration with the community or a benefit to our employees. We bring a long-term heritage built on scientific discovery and backed by a relentless determination to meet the needs of the patients who count on us. We connect with those who are impacted by our efforts, to continually improve how we can meet their needs. And we relentlessly pursue an environment that allows innovation to flourish. All as part of our mission to change lives and brighten futures. At Kyowa Kirin, we will continue to demonstrate the unique value of our medicines for those who need them, to be efficient and agile in the ways we operate in order to achieve more, to inspire and empower our own employees, and to respond to the needs of the communities we serve. We are committed to a bright future, grounded in our desire to bring a smile to people each and every day.